An Evidence-based Physical Therapy Prescription for Adults With X-linked Hypophosphatemia
Karthik Kanamalla1, Rebekah Fuchs2, Casey Herzog2
1Quinnipiac University, Frank H. Netter MD School of Medicine, Department of Medical Sciences, North Haven, Connecticut 06518, USA.
This study developed the first disease-specific physical therapy (PT) program for adults with X-linked hypophosphatemia (XLH). The program improved daily living activities and confidence, addressing lifelong musculoskeletal challenges.
Area of Science:
- Metabolic bone disorders
- Physical therapy and rehabilitation
- Genetics and rare diseases
Background:
- X-linked hypophosphatemia (XLH) is a rare, progressive metabolic disorder causing significant lifelong musculoskeletal issues and physical disability.
- Current management lacks disease-specific physical therapy (PT) recommendations, hindering patient engagement and confidence in daily activities.
- Existing PT approaches do not adequately address the unique challenges faced by adult XLH patients.
Purpose of the Study:
- To develop an evidence-based, patient-centered physical therapy (PT) program for adults with X-linked hypophosphatemia (XLH).
- To address identified gaps in managing adult XLH by creating tailored exercise recommendations.
- To ensure the developed PT program does not impose unintended harm on participants.
Main Methods:
- Program development informed by a prior clinical study on adult XLH physical and functional effects.
- Guided by participant intake data, patient goals, and active range of motion (ROM) assessments.
- Weekly standardized interviews and validated functional tools assessed progression, gains, and concerns.
Main Results:
- A 12-week remote PT program incorporating open and closed kinetic-chain exercises was created and implemented.
- Documented functional improvements and increased patient confidence in performing activities of daily living (ADL).
- Minimal gains in active ROM were noted, consistent with characteristic bony restrictions in XLH.
Conclusions:
- This study presents the first disease-specific PT recommendations for adult X-linked hypophosphatemia (XLH).
- The program aims to mitigate unique physical challenges and can be adapted to individual patient progression.
- These recommendations offer a novel approach to managing the physical and functional limitations associated with XLH.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Introduction to Electrolytes
Role of Sodium
One...


